Magnolia Medical Technologies

Seattle, WA · Founded 2006 · Privately Held (backing)

Developer of a blood-collection system designed to eliminate sepsis misdiagnosis due to the preventable error of false-positive blood culture results caused by contamination. Magnolia Medical Technologies is based in Seattle, WA and was founded in 2006. It was valued at $244 million at its growth round in Jan 2025, the last priced event on record. It has raised $184 million across 6 recorded rounds; the latest was a $43.4 million early-stage round in Jan 2022.

PMV mark · valuation
$244.0M
Oct 2026
Priced at
its growth round
Jan 2025
Total raised
$183.9M
Last round
Early Stage VC
Jan 2022

Who backs Magnolia Medical Technologies?

22 investors
InvestorType
Band of AngelsAngel
Lauder PartnersFamily office
RTW InvestmentsHedge fund
Vivo CapitalVenture capital
HealthQuest CapitalGrowth equity
Vanderbilt University EndowmentOther
Abhijeet Birewar—
Eliette Krakora—
Evidity Health Capital—
Golden Bell Partners—
+ 12 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Magnolia Medical Technologies investors

22 investors are on record for Magnolia Medical Technologies, including Band of Angels, Lauder Partners, RTW Investments and Vivo Capital. The early-stage round in Jan 2022 drew 18 investors.

Free account
More of Magnolia Medical Technologies with a free account
  • ·The complete investor list: 22 names
  • ·Watch Magnolia Medical Technologies: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 22 firms already write checks for companies like Magnolia Medical Technologies. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View